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Abstract
Background: Granular diagnostic criteria for adult malnutrition are lacking. Objective: This study uses analytic morphomics to
define the Morphomic Malnutrition Score (MMS), a robust screening tool for severe malnutrition.Methods: The study population
(n= 643) consisted of 2 cohorts: 1) 124 emergency department patients diagnosed with severe malnutrition by a registered dietitian
(RD) and an available computed tomography (CT) scan within 2 days of RD evaluation, and 2) 519 adult kidney donor candidates
to represent a healthy cohort. Body composition markers of muscle area and abdominal adiposity were measured from patient CT
scans using analytic morphomic assessment, and then converted to sex- and age-adjusted percentiles using the Reference Analytic
Morphomics Population (RAMP). RAMP consists of 6000 patients chosen to be representative of the general population. The
combined cohort was then randomly divided into training (n = 453) and validation (n = 190) sets. MMS was derived using logistic
regression. The model coefficients were transformed into a score, normalized from 0 to 10 (10 = most severe). Results: Severely
malnourished patients had lower amounts of muscle and fat than kidney donors, specifically for dorsal muscle group area at the
twelfth thoracic vertebral level (P< 0.001), psoas muscle area at the fourth lumbar vertebral level (P< 0.001), and subcutaneous fat
area at the third lumbar vertebral level (P < 0.001)—all parameters in MMS. MMS for severely malnourished patients was higher
than kidney donors (7.7 ± 2.2 vs 3.8 ± 2.0, respectively; P-value < 0.001). An MMS > 6.1 was accurate in determining nutrition
diagnosis (82.1% sensitivity; 88.3% specificity; 85.2% balanced accuracy). Conclusions:MMS provides an evidence-based, granular
assessment to distinguish severely malnourished adults from a healthy population. (JPEN J Parenter Enteral Nutr. 2018;42:1263–
1271)
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Clinical Relevancy Statement
A malnutrition score using patient-specific measures of
body composition measured from computed tomography
scans provides a standardized screening criterion for severe
malnutrition in adults. This novel screening tool utilizes
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robust surrogates for fat andmuscle loss to produce a highly
sensitive and specific test for detecting severe malnutrition.
This work is clinically relevant for clinicians who recognize
malnutrition as a risk factor for poor clinical outcomes
and who are aiming for a more efficient and reproducible
method to screen for patients at true risk.
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Introduction
Malnutrition is “an acute, subacute or chronic state of
nutrition, in which a combination of varying degrees of
overnutrition or undernutrition with or without inflamma-
tory activity have led to a change in body composition
and diminished function.”1(p6) Malnutrition contributes to
increased morbidity and mortality in hospitalized adult
patients, including increased risk for developing nosocomial
infection, pressure injury, and other complications.2 Ad-
ditionally, malnutrition is associated with longer hospital
length of stay, increased hospital readmission, and increased
healthcare costs.2
The incidence and prevalence of malnutrition differ
between patient populations and healthcare institutions and
vary based on the assessment tools used to identify malnu-
trition across care settings.3-5 The incidence and prevalence
of malnutrition are somewhat difficult to determine due to a
lack of objective tests that can be used to definitively define
and substantiate the malnutrition diagnosis.3-5 Traditional
malnutrition indices often fail to consider the extent to
which inflammation and illness contribute to the develop-
ment and progression of malnutrition.3-5
In 2012, the American Society for Parenteral and Enteral
Nutrition (ASPEN) and the Academy of Nutrition and Di-
etetics (Academy) jointly published consensus recommen-
dations for the identification and documentation of adult
malnutrition (undernutrition).4 The consensus statement
established standardized criteria for severe and nonsevere
(moderate) malnutrition within 6 domains: energy intake,
weight loss, loss of muscle mass, loss of subcutaneous fat,
localized or generalized fluid that may mask weight loss,
and diminished functional status measured by handgrip
strength. The recommendations outlined etiology-based
definitions for malnutrition based on acute illness/injury,
chronic disease, and starvation.6
The consensus statement aimed to alleviate compliance
challenges in diagnosing and documenting adult malnutri-
tion, using a standardized set of characteristics to generate
consistent and reproducible results. These recommenda-
tions differ from traditional and historic definitions of
malnutrition in identifying malnutrition based on etiol-
ogy, considering multiple manifestations of undernutri-
tion, and discriminating between nonsevere and severe
malnutrition.4,5
Differentiating between mild, moderate, and severe
changes in body composition, as outlined in this paper,
can be challenging and subject to interobserver bias. The
accuracy and reliability of using muscle loss, fat loss, fluid
accumulation, and handgrip strength to diagnose malnu-
trition may be confounded by other variables specific to a
patient’s case, condition, or overall treatment plan. Defini-
tions of mild malnutrition were not included in this paper.
Discrepancy remains between evidence-based best practice
recommendations for malnutrition identification.7 Overall,
rigorous validation of the ASPEN/Academy consensus rec-
ommendations have not been published, and opportunities
exist to develop methods that can objectively measure and
quantify changes in body composition over time.
Analytic morphomics utilizes computed tomography
(CT) scans to provide patient-specific body composition
markers andmay provide the standardization that is lacking
in conventional diagnostics. Previous investigators have
associated morphomic measurements of muscle and fat
with mortality and complications across varying clinical
populations.8-13 We used analytic morphomics measures of
muscle and fat to develop aMorphomicMalnutrition Score
(MMS). We hypothesize that the novel score can serve as a
robust screening tool for severe malnutrition in adults.
Methods
Study Population
MMS is a regression coefficient-based score that was trained
and validated on a retrospectively collected study popu-
lation that consisted of both severely malnourished and
normal patient populations (Figure 1).
The severely malnourished cohort (n = 124) included
the following: adult patients admitted from the Michigan
Medicine emergency department (ED) between 2014 and
2016 who 1) were administered a nutrition assessment by a
registered dietitian (RD) during their encounter; 2) had an
RD note with a nutrition diagnosis of severe malnutrition;
and 3) had a CT scan within 2 days of RD evaluation
that included complete imaging from the tenth thoracic
(T10) through fourth lumbar (L4) vertebral level. Prior to
being included in the analysis, each patient’s medical record
was reviewed retrospectively by a Michigan Medicine RD
to confirm the clinical diagnosis of severe malnutrition
satisfied current Michigan Medicine criteria. Malnutrition
at Michigan Medicine was identified using a standard set
of criteria. The criteria include characteristics for severe
and nonsevere (moderate) malnutrition in specific domains:
weight loss over time, body mass index (BMI), dietary inad-
equacies, and physical signs and symptoms (muscle loss and
fat loss). Patients were classified as severely malnourished
based on the identification of 2 or more characteristics
from 2 different domains (Table 1). Patient age, sex, BMI,
and serum albumin level were retrospectively collected from
electronic medical records. BMI at the time of nutrition
assessment was recorded by the RD; serum albumin level
was obtained proximal to RD evaluation date.
The normal cohort of adult kidney donor candidates
(n = 519) with an appropriate CT scan between 2000 and
2010 was selected to represent a clinically healthy popula-
tion. Despite these patients not having undergone an RD
evaluation, the selection criteria for donor candidates14,15
Lee et al 1265
Figure 1. Study population selection flow chart. CT, computed tomography; ED, emergency department; L, lumbar, RD,
registered dietitian; T, thoracic.
substantiated a nutrition diagnosis of “normal.” Patient
age, sex, BMI, and serum albumin level were retrospec-
tively collected from electronic medical records closest to
patient scan date; inclusion criteria were the same as well.
Both cohorts were combined to form our study population
(n = 643).
Analytic Morphomics
In this study, cross-sectional areas of dorsal muscle group
(DMA), total psoas muscle (TPA), and subcutaneous fat
(SFA) were measured between the T10 through L4 vertebral
levels to observe trends along the torso. The in-depth
methodology on how these morphomic parameters were
measured has been covered extensively in our previous
works.8-13 The CT image processing was performed with
semi-automated algorithms in MatLab 13.0 (MathWorks,
Natick, MA).16 Initially, scans were labeled at each verte-
bral level to provide anatomical landmarks for subsequent
measurements. Cross-sectional area of L3 SFA, T12 DMA,
and L4 TPA were selected from available measurements
(Figure 2). The selection of these measures was based
on previous works demonstrating the clinical relevance of
these CT measures of fat and muscle in clinical popula-
tions. The area measures were then converted into sex-
and age-matched percentiles based on Reference Analytic
Morphomic Population (RAMP) growth curves.17
RAMP
RAMP consists of approximately 6000 patients chosen to
be representative of the general population and includes
both healthy and unhealthy individuals. Chest, abdomen,
and pelvis CT scans were collected from patients aged 1–
91 years, atMichiganMedicine, whowere scanned primarily
for trauma indications. Quantile regression was performed
on each morphomic factor vs age separately for males
and females to generate growth curves corresponding to
the 5th, 25th, 50th, 75th, and 95th percentiles (Figure 3).
This detailed approach to body composition enables the
conversion of individual CT body composition measures
into age- and sex-matched percentiles. Any individual with
a value above the 95th or below the 5th percentile was
assigned to the 95th or 5th, respectively.
Statistical Methods
The study population was randomly split into a training set
(n= 453, 70%) and validation set (n= 190, 30%).Univariate
tests were performed on the training set to assess statistical
significance between patient factors and nutrition diagnosis.
T-tests were used to compare means of continuous vari-
ables; Fisher exact test was used to compare proportions of
binary variables between severely malnourished and normal
patients. Candidate parameters of the morphomics score
were those shown to be associated with patient outcomes
in previous studies8-13 and demonstrated both a significant
relationship and good discrimination ability with nutrition
diagnosis, as measured by P-value and area under the re-
ceiver operating characteristic curve (AUROC), respectively.
Using the training set, a multivariable logistic regression
model with nutrition diagnosis as the dependent variable
was generated with the selected parameters using elastic
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Table 1. Michigan Medicine Adult Malnutrition Diagnosis Guidelines.
Malnutrition
(Moderate)
Malnutrition (Severe,
Protein-Calorie)
ICD-10 Code E44.0 E43
Domain Weight loss Significant weight loss:
1%–2% in 1 week
5% in 1 month
7.5% in 3 months
10% in 6 months
20% in 12 months
Severe weight loss:
> 2% in 1 week
> 5% in 1 month
> 7.5% in 3 months
> 10% in 6 months
> 20% in 12 months
BMI N/A BMI < 18.5
Dietary
inadequacies
> 7 days with a nutrient intake of
 75% of total estimated energy
requirements
or
> 7 days with a nutrient intake of
 75% of baseline/usual intake
 1 month with intake of 50%
of total estimated energy
requirement
or
 1 month with intake of 50%
of baseline/usual intake
Physical findings Mild loss of muscle mass
Mild loss of subcutaneous fat
Moderate or severe loss of muscle
mass
Moderate or severe loss of
subcutaneous fat
Delayed wound healing
Functional status N/A Markedly reduced hand grip
strength (> 2 SD below mean)
A minimum of 2 characteristics from 2 different domains is required for the diagnosis of malnutrition.
Clinical judgement should be used when using this table for the identification of malnutrition.
BMI, body mass index; ICD-10, 10th Revision of the International Classification of Diseases; N/A, not applicable.
net regularization to mitigate the risks of overfitting and
collinearity.18 To create a more intuitive evaluation metric,
the final regression equation was transformed into a score
(MMS) normalized to a range of 0.0–10.0, rounded to the
nearest 10th, with 10.0 being the most severe degree of
malnutrition.
The optimal MMS cutoff to distinguish severe malnutri-
tion from a normal diagnosis was selected to maximize bal-
anced accuracy [(sensi tivi t y + speci f ici t y)/2] The ability
of this method to correctly classify patients as severely
malnourished or normal was assessed by comparing its
sensitivity, specificity, and balanced accuracy in the vali-
dation set to those achieved by using the clinical criteria
of low BMI (< 19 kg/m2) and low serum albumin level
(< 3.5 g/dL), using the RD diagnosis as the benchmark
classification.
Statistical significance was determined by an α-level of
0.05, and statistical analysis was performed in R version
3.4.2.19
This Health Insurance Portability and Accountabil-
ity Act-compliant study was approved by the Medical
School Institutional Review Board at the University of
Michigan. The requirement for informed consent was
waived.
Figure 2. Example of CT scan used in analytic morphomics
assessment. (A) Individual vertebrae were labeled.
(B) Cross-sectional area of dorsal muscle group at T12,
(C) subcutaneous fat (region between purple and yellow lines)
at L3, and (D) psoas muscles at L4 were measured. CT,
computed tomography; L, lumbar; T, thoracic.
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Figure 3. Reference analytic morphomics population growth curves with 5th, 25th, 50th, 75th, and 95th percentiles by age and
(A) sex for dorsal muscle group; (B) total psoas muscle; and (C) subcutaneous fat. The training set severely malnourished
(maroon triangles) and normal (gray circles) cohorts are overlaid atop the growth curves, showing their relative distributions. L,
lumbar; T, thoracic.
Results
Study Population
T-tests and Fisher exact test showed significant differences
(P < 0.001) between normal and severely malnourished
patients in all observed variables (Table 2). Furthermore,
univariate area under the curve (AUC) values showed better
discriminating ability using body composition percentiles
when compared against the clinical predictors of low BMI
and low serum albumin level. Compared with the normal
cohort, the severely malnourished cohort was older; and
a greater proportion were male, had low BMI, and had
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Table 2. Summary Statistics Comparing Severely Malnourished and Normal Cohorts.
Severely Malnourished Normal
Variable Vertebra N Mean SD N Mean SD P-Value AUC
Training Set
Age (years) 96 62.0 14.3 357 40.8 11.6 <.001 0.87
Female 96 41.7% 357 58.3% <.004 0.58
Serum albumin level low
(< 3.5 g/dL)
93 52.7% 354 0.6% <.001 0.76
BMI low (< 19 kg/m2) 86 24.4% 351 0.3% <.001 0.38
Malnutrition score 96 7.7 2.2 357 3.8 2.0 <.001 0.89
DMAcentile T10 96 27.5 23.6 357 59.1 26.6 <.001 0.81
DMAcentile T11 96 23.3 22.4 357 61.6 25.2 <.001 0.87
DMAcentile T12 96 21.9 23.7 357 59.6 24.8 <.001 0.87
DMAcentile L1 96 22.7 22.6 357 54.4 25.9 <.001 0.83
TPAcentile L4 96 27.3 24.1 357 58.3 26.6 <.001 0.81
SFAcentile T10 96 32.0 29.1 357 59.9 23.6 <.001 0.77
SFAcentile T11 96 31.1 29.6 357 61.5 23.1 <.001 0.79
SFAcentile T12 96 31.3 30.2 357 62.6 23.0 <.001 0.79
SFAcentile L1 96 31.7 30.6 357 63.6 22.9 <.001 0.79
SFAcentile L2 96 31.8 30.0 357 62.7 22.7 <.001 0.79
SFAcentile L3 96 30.7 28.8 357 62.0 22.7 <.001 0.80
SFAcentile L4 96 30.1 28.5 357 60.3 23.0 <.001 0.79
Validation Set
Age 28 57.1 16.9 162 40.6 11.2 <.001 0.78
Female 28 54% 162 66% 0.208 0.56
Serum albumin level low
(< 3.5 g/dL)
27 63% 157 0% <.001 0.81
BMI low (< 19 kg/m2) 24 42% 159 0% < .001 0.29
Malnutrition score 28 8.1 1.9 162 3.5 2.0 < .001 0.94
DMAcentile T10 28 26.8 28.2 162 63.5 23.6 < .001 0.84
DMAcentile T11 28 22.8 26.7 162 66.0 24.3 < .001 0.88
DMAcentile T12 28 22.8 27.5 162 63.7 24.7 < .001 0.87
DMAcentile L1 28 25.5 29.9 162 58.1 25.1 < .001 0.81
TPAcentile L4 28 22.5 21.8 162 63.5 24.6 < .001 0.89
SFAcentile T10 28 21.0 15.3 162 61.4 23.3 < .001 0.91
SFAcentile T11 28 20.6 15.7 162 62.1 22.4 < .001 0.92
SFAcentile T12 28 21.3 15.9 162 63.5 21.8 < .001 0.93
SFAcentile L1 28 21.1 16.2 162 64.1 21.0 < .001 0.94
SFAcentile L2 28 20.2 15.3 162 64.3 20.6 < .001 0.95
SFAcentile L3 28 18.6 14.3 162 63.4 21.0 < .001 0.95
SFAcentile L4 28 18.1 14.3 162 61.4 22.2 < .001 0.94
Variables used in the malnutrition score in bold.
AUC, area under the curve; BMI, body mass index; DMA, dorsal muscle group; L, lumbar; SFA, subcutaneous fat; T, thoracic; TPA, total psoas
muscle.
low serum albumin level. The severely malnourished cohort
had lower percentiles across all measured vertebra levels for
DMA, TPA, and SFA.
Malnutrition Scoring and Classification
Multivariable logistic regression demonstrated that low
muscle and fat area percentiles were associated with severe
malnutrition (regression coefficients, L3 SFAcentile: −0.025;
L4 TPAcentile: −0.020; T12 DMAcentile: −0.036). After
normalization, the final MMS equation was:
MMS = 10.55 − (.0343 ∗SFAcentile) − (.0274 ∗TPAcentile)
− (.0494 ∗DMAcentile)
Patients with severe malnutrition had higher MMS than
normal patients (7.7 ± 2.2 vs 3.8 ± 2.0, respectively; P-
value < 0.001). MMS had an AUROC of 0.89 in the
training set and 0.94 in the validation set (Figure 4a). A
cutoff score of MMS > 6.1 maximized balanced accuracy
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Figure 4. (A) Sensitivity, specificity, and balanced accuracy of various score cutoffs on the training set, showing the optimum
score cutoff at 6.1. (B) Performance of AUROC curve of multivariable logistic regression model performance on training and
validation sets. (C) Distribution of scores for normal vs severely malnourished cohorts in both training and validation sets.
AUC, area under the curve.
in the training set and was selected to distinguish between
a nutrition diagnosis of severe and normal (Figure 4b). The
distribution of scores in the training set and validation set
were similar; however, the improved AUC was attributed
to the paucity of low scores in the severely malnourished
cohort in the validation set (Figure 4c). In the validation
set, low BMI had a sensitivity of 41.7%, specificity of 100%,
and balanced accuracy of 70.8%; low serum albumin level
had a sensitivity of 63%, specificity of 100%, and balanced
accuracy of 81.5%; andMMS > 6.1 produced sensitivity of
82.1%, specificity of 88.3%, and balanced accuracy of 85.2%
(Table 3).
Discussion
In this study, we present a novel standardized screening tool
for severe malnutrition that utilizes sex- and age-adjusted
reference percentiles of muscle area and abdominal adi-
posity incidentally imaged by CT performed for unrelated
clinical indications. Lower percentiles of TPA area, DMA
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Table 3. Performance of High Malnutrition Score, Low Serum Albumin Level, and Low BMI in Classifying Patients as Severely
Malnourished vs Registered Dietitian Diagnosis.
Dataset Model Specificity Sensitivity Balanced Accuracy
Training High MMS (> 6.1) 85.7% 80.2% 83.0%
Low serum albumin level (< 3.5 g/dL) 99.4% 52.7% 76.1%
Low BMI (< 19 kg/m2) 99.7% 24.4% 62.1%
Validation High MMS (> 6.1) 88.3% 82.1% 85.2%
Low serum albumin level (< 3.5 g/dL) 100.0% 63.0% 81.5%
Low BMI (< 19 kg/m2) 100.0% 41.7% 70.8%
BMI, body mass index; MMS, Morphomic Malnutrition Score.
area, and SFA demonstrated a strong association with
a severe malnutrition diagnosis. The multivariate model
from which MMS was derived was internally validated
and demonstrated improved accuracy in classifying severely
malnourished vs normal patients when compared with low
BMI or low serum albumin level alone. Scores for severely
malnourished patients were significantly higher than pa-
tients diagnosed as normal. Furthermore, the cutoff value
for severe malnutrition generated a highly sensitive diagnos-
tic test. Internal validation of the score cutoff generated
the highest sensitivity when compared against indicators for
low BMI and low serum albumin level. Within this context,
high sensitivity is most useful for MMS to avoid incorrectly
refuting the presence of a potentially treatable risk factor
such as malnutrition.
The recent consensus statement from ASPEN and the
Academy proposed a set of characteristics to improve
malnutrition identification. Their criteria included intake,
weight loss, loss of muscle mass, loss of subcutaneous fat,
localized or generalized fluid, and diminished functional
status to provide an etiology-based approach to make
malnutrition diagnostics more reproducible and easier to
define. BMI was among the parameters in theMichigan RD
nutrition assessment. BMI is recognized as a widely used
indicator for obesity and nutrition status; however, previous
studies have shown that it is unable to discern lean mass
content from body fat mass.20 Albumin is another common
diagnostic criteria that previous investigators—including
ASPEN and the Academy—have demonstrated to be an
insensitive and nonspecific indicator of nutrition status.4
Neither BMI nor serum albumin level alone are reasonable
screening criteria for severe malnutrition; however, they
were the available criteria that were retrospectively available
for all study patients. Because low BMI is included in the
existing RD diagnosis, we would expect it to perform rea-
sonably well. However, serum albumin level is not included
in the RD diagnosis and was only included due to its previ-
ous use by other investigators.21,22 Like those investigators,
we do not recommend using low serum albumin level as an
indicator of malnutrition in hospitalized patients because
serum albumin level is an acute phase reactant and plasma
levels are decreased in a number of disease states unrelated
to nutrition status such as injury, inflammation, sepsis, fluid
shifts and anasarca, and synthetic liver dysfunction. MMS
aims to inform the development of an objective screening
protocol by providing a quantitative assessment of muscle
and fat, independent of factors such as BMI and serum
albumin level, to better characterize body changes caused
by malnutrition.
Conclusions
There are limitations to this study. First, this is a retrospec-
tive study and is subject to biases of such methodology.
Our study population was also from a single institution.
Although we cannot argue that it is representative of a
general ED patient population, the opportunity to produce
a novel diagnostic criterion for severe malnutrition using
reproducible methods was deemed worthwhile to work
within the shortcomings of our data. Our nutrition diag-
nosis of kidney donor candidates as “normal” has not been
validated by clinicians or health centers outside of this work.
Evaluation for kidney donation at Michigan Medicine is
available to those who are genuinely willing to donate;
physically fit; in good general health; and free from diabetes,
cancer, kidney disease, and heart disease. The predonation
evaluation includes assessment by a nephrologist, transplant
surgeon, and a social worker, and candidates only receive a
CT if they have completed their evaluation andwere deemed
an excellent candidate to donate a kidney. Classifying these
successful candidates as nutritionally “normal” was a clin-
ically based decision that involved both the RD and the
physicians. The exclusion of all other ED patients with a
nonsevere (eg, moderate, none) nutrition diagnosis presents
bias.However, the characteristics of severemalnutrition had
the most objective criteria to substantiate the diagnosis.
Furthermore, it was our objective to first assess whether
our novel markers of muscle and fat could quantitatively
distinguish a healthy patient from the severelymalnourished
population.
Future works will focus on investigating clinical popu-
lations where malnutrition is prevalent and CT imaging is
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part of the treatment protocol. Calculating MMS of other
populations and associating it with clinical outcomes can
inform the link between malnutrition and poor outcomes.
Patient claims data is also desirable in order to determine
whether an MMS screen positive for severe malnutrition
is associated with higher episode costs. MMS serves as a
robust indicator of a widely recognized risk factor that is
not clearly defined, yet likely modifiable if administered the
appropriate regimen. Furthermore, MMS utilizes patient-
specific data measured from CT scans performed for other
medical indications, making implementation simple and
scalable for screening to identify patients who would benefit
from RD assessment and intervention for malnutrition.
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